NCT05824936

Brief Summary

The goal of this pilot interventional study is to learn about the implementation of a home monitoring program (using remote study visits and lung function testing) in children with asthma. The main questions to answer are:

  1. 1.Do participants find the program to be feasible, acceptable and accessible?
  2. 2.What factors are associated with completion of the program?
  3. 3.Does the program have an effect on asthma control and daytime sleepiness?

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
15

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Jun 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

March 20, 2023

Completed
1 month until next milestone

First Posted

Study publicly available on registry

April 24, 2023

Completed
2 months until next milestone

Study Start

First participant enrolled

June 8, 2023

Completed
9 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

February 19, 2024

Completed
11 days until next milestone

Study Completion

Last participant's last visit for all outcomes

March 1, 2024

Completed
1.2 years until next milestone

Results Posted

Study results publicly available

May 20, 2025

Completed
Last Updated

May 20, 2025

Status Verified

May 1, 2025

Enrollment Period

9 months

First QC Date

March 20, 2023

Results QC Date

February 5, 2025

Last Update Submit

May 15, 2025

Conditions

Keywords

asthmaspirometrytelehealth

Outcome Measures

Primary Outcomes (3)

  • Feasibility (Retention %)

    Feasibility will be evaluated by calculating retention rates at week 24.

    24 weeks

  • Acceptability

    To measure acceptability, the study-specific Satisfaction and Usability Survey will be used and assessed at item-level. The percentage (%) of participants who respond "agree" or "strongly agree" to each item will be measured.

    24 weeks

  • Accessibility

    The frequency (%) of any technical or connectivity issues at each visit will be recorded throughout the study.

    24 weeks

Secondary Outcomes (6)

  • Explore the Preliminary Effectiveness of the Pilot Program on Asthma Control.

    Baseline and Week 24

  • Explore the Preliminary Effectiveness of the Pilot Program on Daytime Sleepiness.

    Baseline and Week 24

  • Explore Patient and Family-related Demographic Characteristics and Psychosocial Factors Associated With Successful Completion of the Intervention.

    24 weeks

  • Explore Asthma-related Factors Associated With Successful Completion of the Intervention (Oral Steroid Usage)

    Baseline

  • Explore Asthma-related Factors Associated With Successful Completion of the Intervention (ER Visits)

    Baseline

  • +1 more secondary outcomes

Study Arms (1)

Pilot study arm for technology-enhanced asthma intervention

EXPERIMENTAL

All participants will be in the pilot arm for technology-enhanced intervention program.

Behavioral: Pilot study arm for technology-enhanced asthma intervention

Interventions

Participants will be enrolled in a remote monitoring program using monthly remote study visits which will include the use of a mobile spirometer (device for testing lung function). Participants will complete monthly remote study visits visits using telehealth platform and will complete lung function testing during the visit using a mobile spirometer as well as remote study measures.

Pilot study arm for technology-enhanced asthma intervention

Eligibility Criteria

Age12 Years - 18 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • Followed by a Primary Care Practice meeting HRSA rural or medically underserved designation status
  • Diagnosis of persistent asthma: on at least 1 controller/ preventative medication for asthma
  • Ability to follow directions and perform study measures, including in-office spirometry at initial visit
  • Access to mobile device with internet connectivity to connect to telehealth visit and mobile spirometer application

You may not qualify if:

  • Significant cardiopulmonary disease other than asthma (Examples: Cystic Fibrosis, complex congenital heart disease)
  • Non-English Speaking

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Nemours Children's Health

Wilmington, Delaware, 19803, United States

Location

MeSH Terms

Conditions

Asthma

Condition Hierarchy (Ancestors)

Bronchial DiseasesRespiratory Tract DiseasesLung Diseases, ObstructiveLung DiseasesRespiratory HypersensitivityHypersensitivity, ImmediateHypersensitivityImmune System Diseases

Results Point of Contact

Title
Dr. Abigail Strang
Organization
Nemours Children's Hospital

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Model Details: 15 participants will be enrolled in single-group pilot study to measure acceptability, feasibility, and accessibility of mobile spirometry for asthma
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
PI/MD

Study Record Dates

First Submitted

March 20, 2023

First Posted

April 24, 2023

Study Start

June 8, 2023

Primary Completion

February 19, 2024

Study Completion

March 1, 2024

Last Updated

May 20, 2025

Results First Posted

May 20, 2025

Record last verified: 2025-05

Data Sharing

IPD Sharing
Will not share

Locations